Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis.
Saved in:
| Title: | Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis. |
|---|---|
| Authors: | Wang, Yin-Che1 (AUTHOR), Lin, Cheng-Hsien1 (AUTHOR), Su, Yu-Chen1,2 (AUTHOR), Teng, Chieh-Lin Jerry1,3,4,5,6,7 (AUTHOR) drteng@vghtc.gov.tw |
| Source: | Hematology. Dec2025, Vol. 30 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10245332 |
|---|---|
| DOI: | 10.1080/16078454.2025.2462249 |
